Daisy Wolf combines a JD from Yale Law School with an MBA from Stanford GSB and experience at Meta leading government and politics growth efforts, giving her an unusually strong background in both regulation and Big Tech operations for evaluating healthcare startups. She focuses specifically on the intersection of healthcare, consumer experience, and fintech, arguing that AI will be the technology that finally makes healthcare 10x better and actively champions seasoned tech founders from companies like Instacart and Spotify who are now building in health.

• Deep interest in the intersection of artificial intelligence and healthcare, specifically regarding foundation models that tackle complex fields like psychology. She highlighted this when discussing her firm's backing of Slingshot AI, noting that the best founders often take on the messiest and largest problems like mental health access.
• Strong conviction that behavior change and preventative care are more critical than just treating existing illnesses. She shared a thread arguing that while curing cancer is vital, it would only add a few years to average lifespans, whereas addressing the eighty percent of deaths caused by preventable lifestyle conditions is the real key to longevity.
• A focus on the concept of food as medicine and the idea that America's health crisis requires urgent intervention. This was a central theme in her support for Truemed, where she praised the founder's vision that fixing the nation's metabolic health through diet and exercise is essential for the country's future.
• Enthusiasm for consumer-focused health tools that democratize access to personal data. She pointed to her investment in Function as a way to help people use their own biological data to live a hundred healthy years, likening the shift to a major unlock for longevity similar to how previous outsiders reimagined consumer experiences.
• Support for advancements in women's health and reproductive rights. She has posted about the importance of demanding better medical treatment for women, specifically citing issues ranging from fertility to postpartum care and celebrating expanded access to reproductive medications at major pharmacies.